Workflow
TherapeuticsMD(TXMD) - 2020 Q2 - Earnings Call Transcript

TherapeuticsMD, Inc. (NASDAQ:TXMD) Q2 2020 Earnings Conference Call August 6, 2020 8:30 AM ET Company Participants Nichol Ochsner - Vice President of Investor Relations Robert Finizio - Chief Executive Officer James D’Arecca - Chief Financial Officer Dawn Halkuff - Chief Commercial Officer Mitch Krassan - Chief Strategy and Performance Officer Conference Call Participants Jen Kim - Cantor Fitzgerald Stacy Ku - Cowen and Company Douglas Tsao - H.C. Wainwright Annabel Samimy - Stifel Financial Corp. Operator ...